
NYSEHealthcareMedical - Instruments & Supplies
最新数据
US$125.7
+US$0.58 · +0.46%
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
前收盘价
US$125.7
+US$0.58 · +0.46%
盘后
US$125.13
−US$0.57 · -0.45%
10月12日 18:02 ET
盘中时间采用ET。市场数据可能有所延迟。
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
日内区间
当前US$125.7
52周区间
当前US$125.7
盘中时间采用ET。市场数据可能有所延迟。
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
日内区间
当前US$125.7
52周区间
当前US$125.7
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 19.93亿 USD | 30.47亿 USD | 29.74亿 USD | 27.91亿 USD | 28.1亿 USD |
| 销货成本 | 8.72亿 USD | 13.45亿 USD | 13.28亿 USD | 12.6亿 USD | 12.6亿 USD |
| 毛利 | 11.21亿 USD | 17.03亿 USD | 16.47亿 USD | 15.31亿 USD | 15.5亿 USD |
| 研究与开发 | 1.45亿 USD | 1.62亿 USD | 1.54亿 USD | 1.54亿 USD | 1.31亿 USD |
| 销售、一般及管理费用 | 7.2亿 USD | 9.95亿 USD | 9.3亿 USD | 8.64亿 USD | 8.6亿 USD |
| 营业费用 | 8.65亿 USD | 15.52亿 USD | 11.41亿 USD | 10.31亿 USD | 9.22亿 USD |
| 利息收入 | 640.3万 USD | 800.9万 USD | 1278.1万 USD | 91.2万 USD | 132.8万 USD |
| 利息支出 | 1亿 USD | 8354.4万 USD | 8508.2万 USD | 5426.4万 USD | 5696.9万 USD |
| 折旧和摊销 | 1.78亿 USD | 2.75亿 USD | 2.42亿 USD | 2.31亿 USD | 2.37亿 USD |
| 营业利润 | 2.56亿 USD | 1.51亿 USD | 5.06亿 USD | 5亿 USD | 6.28亿 USD |
| 净利润 | −9.06亿 USD | 6967.5万 USD | 3.56亿 USD | 3.63亿 USD | 4.85亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$155.25
上涨空间 23.51%年度分割调整后的每股现金分配。
US$1.36
2025年(完整年度)0.0% 自从 2021
2026年(部分年度):US$1.02
US$1.36
2,021
US$1.36
2,022
US$1.36
2,023
US$1.36
2,024
US$1.36
2,025
US$1.02
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年8月14日 | US$0.34Quarterly | 2026年8月14日 | 2026年9月30日 |
股息 | 2026年5月22日 | US$0.34Quarterly | 2026年5月25日 | 2026年6月30日 |
股息 | 2026年3月6日 | US$0.34Quarterly | 2026年3月6日 | 2026年3月31日 |
股息 | 2025年11月14日 | US$0.34Quarterly | 2025年11月14日 | 2025年12月15日 |
股息 | 2025年8月15日 | US$0.34Quarterly | 2025年8月15日 | 2025年9月15日 |
股息 | 2025年5月20日 | US$0.34Quarterly | 2025年5月20日 | 2025年6月16日 |
除息 2026年8月14日
US$0.34
Quarterly
2026年8月14日登记 · 支付日 2026年9月30日
除息 2026年5月22日
US$0.34
Quarterly
2026年5月25日登记 · 支付日 2026年6月30日
除息 2026年3月6日
US$0.34
Quarterly
2026年3月6日登记 · 支付日 2026年3月31日
除息 2025年11月14日
US$0.34
Quarterly
2025年11月14日登记 · 支付日 2025年12月15日
除息 2025年8月15日
US$0.34
Quarterly
2025年8月15日登记 · 支付日 2025年9月15日
除息 2025年5月20日
US$0.34
Quarterly
2025年5月20日登记 · 支付日 2025年6月16日
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2亿0.01%2.3万亿 USD0.03%US$381.57-0.10%
Vanguard Morningstar Small-Cap ETFVB1.45亿0.08%1853亿 USD0.03%US$288.16-0.46%
Vanguard Morningstar Small-Cap Value ETFVBR9189.03万0.13%682亿 USD0.05%US$234.71+0.12%
Vanguard Extended Market ETFVXF7307.82万0.08%954亿 USD0.05%US$233.52-0.63%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM4854.96万0.31%157.12亿 USD0.03%US$53.42-0.06%
Dimensional - US Small Cap ETFDFAS4318.27万0.13%338.69亿 USD0.31%US$78.17-0.23%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV4109.74万0.15%268.09亿 USD0.33%US$37.98+0.08%
Schwab U.S. Small-Cap ETFSCHA2816.94万0.13%218.24亿 USD0.03%US$32.66-0.40%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
Dimensional - US Small Cap ETFDFAS
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Schwab U.S. Small-Cap ETFSCHAAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。